AptarGroup, Inc. (ATR) Financials
ATR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 5.1 billion | 2.4 billion |
| Dec. 31, 2025 | 5.3 billion | 2.5 billion |
| Sept. 30, 2025 | 5.1 billion | 2.3 billion |
| June 30, 2025 | 4.9 billion | 2.1 billion |
ATR Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 53.3 million | 16.8 million |
| Dec. 31, 2025 | 96.9 million | 7.2 million |
| Sept. 30, 2025 | 114.3 million | 17.1 million |
| June 30, 2025 | 61.0 million | 8.0 million |
ATR Net Income
| Date | Net Income |
|---|---|
| March 31, 2026 | 72.8 million |
| Dec. 31, 2025 | 74.3 million |
| Sept. 30, 2025 | 127.8 million |
| June 30, 2025 | 111.7 million |
ATR Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 229.5 million | 1.1 billion | 44.0 million |
| Dec. 31, 2025 | 409.5 million | 1.1 billion | 47.9 million |
| Sept. 30, 2025 | 264.8 million | 546.0 million | 49.2 million |
| June 30, 2025 | 169.8 million | 535.1 million | 49.7 million |
ATR Shares Outstanding
ATR Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 65.4 million | 167.6 million | 167.6 million | - |
| Dec. 31, 2025 | 86.8 million | 151.3 million | 151.0 million | - |
| Sept. 30, 2025 | 63.3 million | 455.2 million | 148.8 million | - |
| June 30, 2025 | 65.0 million | 306.4 million | 151.1 million | - |
ATR Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 982.9 million | 706.7 million |
| Dec. 31, 2025 | 962.7 million | 701.1 million |
| Sept. 30, 2025 | 961.1 million | 673.3 million |
| June 30, 2025 | 966.0 million | 668.9 million |
ATR Revenue by Segment
ATR
List: Champions
Price: $112.53
Dividend Yield: 1.68%
Forward Dividend Yield: 1.71%
Payout Ratio: 37.82%
Dividend Per Share: 1.92 USD
Earnings Per Share: 5.85 USD
P/E Ratio: 20.96
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 284100
Ebitda: 129.6 millionMarket Capitalization: 7.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 34
DGR3: 5.88%
DGR5: 4.63%
DGR10: 4.90%
DGR20: 9.66%